Grifols SA (GRFS)
6.425
-0.06
(-0.85%)
USD |
NASDAQ |
Apr 24, 10:28
Grifols Cash from Investing (TTM)
Cash from Investing (TTM) Chart
Historical Cash from Investing (TTM) Data
| Date | Value |
|---|---|
| June 30, 2021 | -1.486B |
| March 31, 2021 | -1.538B |
| December 31, 2020 | -979.99M |
| September 30, 2020 | -535.25M |
| June 30, 2020 | -374.76M |
| March 31, 2020 | -451.33M |
| December 31, 2019 | -614.37M |
| September 30, 2019 | -592.09M |
| June 30, 2019 | -1.015B |
| March 31, 2019 | -1.092B |
| December 31, 2018 | -923.24M |
| September 30, 2018 | -822.23M |
| June 30, 2018 | -735.64M |
| March 31, 2018 | -615.53M |
| December 31, 2017 | -2.476B |
| September 30, 2017 | -2.541B |
| June 30, 2017 | -2.332B |
| March 31, 2017 | -2.438B |
| December 31, 2016 | -560.74M |
| September 30, 2016 | -520.89M |
| Date | Value |
|---|---|
| June 30, 2016 | -528.94M |
| March 31, 2016 | -351.00M |
| December 31, 2015 | -702.56M |
| September 30, 2015 | -742.93M |
| June 30, 2015 | -697.66M |
| March 31, 2015 | -745.99M |
| December 31, 2014 | -2.023B |
| September 30, 2014 | -1.998B |
| June 30, 2014 | -2.040B |
| March 31, 2014 | -1.967B |
| December 31, 2013 | -313.47M |
| September 30, 2013 | -282.10M |
| June 30, 2013 | -215.38M |
| March 31, 2013 | -93.98M |
| December 31, 2012 | -82.84M |
| September 30, 2012 | 62.22M |
| June 30, 2012 | 46.79M |
| March 31, 2012 | -2.299B |
| December 31, 2011 | -2.257B |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (TTM) Range, Past 5 Years
-1.538B
Minimum
Mar 2021
-374.76M
Maximum
Jun 2020
-842.96M
Average
-614.37M
Median
Dec 2019
Cash from Investing (TTM) Benchmarks
| DBV Technologies SA | -0.808M |
| Adaptimmune Therapeutics PLC | 176.54M |
| Biodexa Pharmaceuticals Plc | -0.3289M |
| NuCana PLC | 3.594M |
| Autolus Therapeutics PLC | -10.99M |